What are the associations between ischemic stroke follow-up, socioeconomic status, and adherence to secondary preventive drugs?
Adherence to secondary preventive drugs decreases over the first year after ischemic stroke, highlighting a need to address specific reasons for nonadherence.
The use of secondary preventive drugs decreases over the first year after stroke and remains suboptimal. Specific reasons for nonadherence warrant further study.
Ullberg et al. (Sun,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: